Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) December weekly option implied volatility is at 55, December is at 51; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 3.9 calls to 1 put with a focus on 1600 contracts of October 2 weekly 24 calls into quarter results
• Western Digital (WDC) call put ratio 1.6 calls to 1 put with a focus on expiring September 25 calls
• Lowe's Cos. (LOW) call put ratio 1 call 1.5 puts as share price near low end of range